Navigation Links
Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
Date:12/6/2007

mast cells by blocking the activation of syk kinase.

R343 will be delivered via the inhaled route using a dry powder inhaler and will initially be tested in healthy volunteers to evaluate its safety, dosing and pharmacodynamics. R343 is not orally bio-available and is a different molecule from R788. R788 is an orally bio-available syk kinase inhibitor in development by Rigel for various autoimmune and hematological indications and is not part of this collaboration.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the clinical development of R343 and the potential efficacy of Rigel's product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "may," "expects," "goal" and similar expressions are intended to identify these forward-looking statements. These forward-looking statements are based upon Rigel's current expectations. Forward-looking statements involve risks and uncertainties. There are a number of i
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- The number of people overdosing from opioid prescription ... percent of the workforce has misused prescription painkillers, according ... making opioid use a serious threat to employee safety. ... correct dosage with a valid prescription, subtle impairment may ... Safety Council released a guide for employers, ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... -- Elekta (NSE:EKTAb) and Royal Philips (NYSE: ... Trust ( Manchester, UK ), a specialist ... to develop the clinical value of an integrated magnetic ... system would, in principle, improve the practice of radiotherapy ... "The Christie was an essential participant in the project ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... Lilly and Company (NYSE: LLY ) announced ... Lilly to access innovation being developed outside the company,s ... independent venture capital firms participating in the Mirror Portfolio ... stage of their development. The first is a molecule ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... launched Voriconazole Tablets, 50 mg and 200 mg, under ... Inc. Mylan was the first company to have filed ... for Voriconazole Tablets and was awarded 180 days of ...
Cached Medicine Technology:Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 2Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 3Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 4
(Date:7/22/2014)... 2014 Two individuals from Meditec, a ... Association for Healthcare Documentation Integrity (AHDI) Awards. One nominee ... the sole nominee for both the Excellence in Credentialing ... Linda Curia, is also nominated for the Rising Star ... field for over 18 years in a wide-variety of ...
(Date:7/22/2014)... NY (PRWEB) July 22, 2014 As ... Icahn School of Medicine at Mount Sinai have helped ... with the risk of developing schizophrenia, in the largest ... conducted with 80,000 people. The findings, published online in ... underlie schizophrenia, and could lead to new approaches to ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 University ... officially opened the doors of its state-of-the-art, $151 ... in the heart of downtown San Francisco's South of ... 10,000 patients a year. Those patients will now be ... sophisticated iKiosks . , Advanced Kiosks engineering ...
(Date:7/22/2014)... 22, 2014 (HealthDay News) -- Genetic fragments of the deadly ... where an infected camel was kept, a new study says. ... determine if Middle East Respiratory Syndrome (MERS) can be transmitted ... samples over three consecutive days from a camel barn owned ... the town of Jeddah, Saudi Arabia. The man later died. ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
Breaking Medicine News(10 mins):Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 2Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2
... pleased to announce the appointment of Dr. Elisa J. Zinberg as ... effective immediately. , ... Rye, NY (PRWEB) September 23, ... Elisa J. Zinberg as Vice - President of Operations, and member ...
... The ALS Association,s comprehensive Assistive Technology Consultation Program. The program ... ALS, also known as Lou Gehrig,s Disease, and training on available ... at the Associaton,s Chapters and Certified Centers of Excellence. , ... ...
... Coinstar Centers(R) at retail locations,nationwide, WASHINGTON, Sept. 22 ... to those affected by the recent,hurricanes by donating their ... retail locations. Simply select the Red Cross Disaster Relief ... Cross to provide immediate,food, shelter, counseling and other assistance ...
... Reasons for slowed time to treatment remain unclear, experts say ... including those on Medicaid, are more likely to take much ... strikes compared to more affluent people, a new study finds. ... at a greater risk of missing a critical window for ...
... SACRAMENTO, Calif., Sept. 22 The California Office of,Traffic Safety ... riding in car safety seats. The 2008 rate of 94.4 ... a big jump of 6.7,percentage points over the 2007 rate ... time to kick off the national Child,Passenger Safety Week, September ...
... model, it appears that comparing the benefits and risks ... and their physicians choose appropriate screening strategies, according to ... Archives of Internal Medicine , one of the JAMA/Archives ... known as Pap smears, is credited with reducing the ...
Cached Medicine News:Health News:Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 3Health News:Americans Urged to Support American Red Cross Disaster Relief Efforts for Hurricanes of 2008 2Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Record Upsurge in State's Child Safety Seat Usage Marks Child Passenger Safety Week 2Health News:Model highlights benefits and risks of cervical cancer screening methods 2
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
96-Well PCR Plate Sealing Mat...
Inquire...
Inquire...
Medicine Products: